Ensysce Biosciences (ENSCW) Amortizatization of Intangibles (2020 - 2021)
Ensysce Biosciences (ENSCW) reported Amortizatization of Intangibles of $771556.0 for Q2 2021, up 134.92% year-over-year from $328429.0 in Q2 2020, and up 342.37% quarter-over-quarter from $174413.0 in Q1 2021.
Ensysce Biosciences (ENSCW) Amortizatization of Intangibles (2020 - 2021) Analysis & Trends
Ensysce Biosciences (ENSCW) has 2 years of Amortizatization of Intangibles data on file, last reported at $771556.0 in Q2 2021.
- Amortizatization of Intangibles for Q2 2021 came in at $771556.0, up 134.92% year-over-year; the trailing twelve-month figure through Dec 2021 was $945969.0 (up 54.16% YoY), and the FY2021 annual result was $945969.0, up 54.16% from the prior year.
- Amortizatization of Intangibles grew to $771556.0 in Q2 2021 per ENSCW's latest filing, from $174413.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $771556.0 in Q2 2021 and troughed at $31428.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ensysce Biosciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 771,556.00 |
| Jun 30, 2021 | 771,556.00 |
| Mar 31, 2021 | 174,413.00 |
| Mar 31, 2021 | 174,413.00 |
| Dec 31, 2020 | 139,149.00 |
| Dec 31, 2020 | 139,149.00 |
| Sep 30, 2020 | 114,604.00 |
| Sep 30, 2020 | 114,604.00 |
| Jun 30, 2020 | 328,429.00 |
| Jun 30, 2020 | 328,429.00 |
| Mar 31, 2020 | 31,428.00 |
| Mar 31, 2020 | 31,428.00 |